Results 201 to 210 of about 1,335,871 (234)

Acquiring tissue for advanced lung cancer diagnosis and comprehensive biomarker testing: A National Lung Cancer Roundtable best‐practice guide

Ca-A Cancer Journal for Clinicians, 2023
Adam Fox
exaly  

Oligometastatic Non-Small-Cell Lung Cancer

International Journal of Radiation Oncology*Biology*Physics, 2015
David A. Palma, Gregory M.M. Videtic
openaire   +2 more sources

Racial and socioeconomic disparities in lung cancer screening in the United States: A systematic review

Ca-A Cancer Journal for Clinicians, 2021
Ernesto Sosa, Dan J Raz, Virginia Chih-Yi Sun   +2 more
exaly  

Staging non-small cell lung cancer

Clinical Radiology, 1993
P, Armstrong, J M, Vincent
openaire   +2 more sources

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial.

The Lancet, 2016
R. Herbst, P. Baas, Dong-Wan Kim, E. Felip, J. Pérez-Gracia, Ji-Youn Han, J. Molina, Joo‐Hang Kim, C. D. Arvis, M. Ahn, M. Majem, M. Fidler, G. de Castro, M. Garrido, G. Lubiniecki, Shentu Yue, E. Im, M. Dolled-Filhart, E. Garon   +18 more
semanticscholar   +1 more source

Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer

Nature, 2007
M. Soda, Y. L. Choi, Munehiro Enomoto, S. Takada, Y. Yamashita, S. Ishikawa, Shin-ichiro Fujiwara, Hideki Watanabe, K. Kurashina, Hisashi Hatanaka, M. Bando, S. Ohno, Y. Ishikawa, H. Aburatani, T. Niki, Y. Sohara, Y. Sugiyama, H. Mano   +17 more
semanticscholar   +1 more source

The biology and management of non-small cell lung cancer

Nature, 2018
R. Herbst, D. Morgensztern, C. Boshoff
semanticscholar   +1 more source

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.

The Lancet Oncology, 2012
R. Rosell, E. Carcereny, R. Gervais, A. Vergnenègre, B. Massutí, E. Felip, R. Palmero, R. García-Gómez, C. Pallarés, J. Sánchez, R. Porta, M. Cobo, P. Garrido, F. Longo, T. Morán, A. Insa, F. de Marinis, R. Corre, I. Bover, A. Illiano, É. Dansin, J. de Castro, M. Milella, N. Reguart, G. Altavilla, U. Jiménez, M. Provencio, M. Moreno, J. Terrasa, J. Muñoz-Langa, J. Valdivia, D. Isla, M. Dómine, O. Molinier, J. Mazières, N. Baize, R. García-Campelo, G. Robinet, D. Rodríguez-Abreu, G. López-Vivanco, V. Gebbia, Lioba Ferrera-Delgado, P. Bombaron, R. Bernabé, A. Bearz, Á. Artal, E. Cortesi, C. Rolfo, M. Sánchez-Ronco, A. Drozdowskyj, C. Queralt, I. de Aguirre, J. Ramírez, J. Sánchez, M. Molina, M. Taron, L. Paz-Ares   +56 more
semanticscholar   +1 more source

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial.

The Lancet Oncology, 2010
T. Mitsudomi, S. Morita, Y. Yatabe, S. Negoro, I. Okamoto, J. Tsurutani, T. Seto, M. Satouchi, H. Tada, T. Hirashima, K. Asami, N. Katakami, M. Takada, H. Yoshioka, K. Shibata, S. Kudoh, E. Shimizu, H. Saito, S. Toyooka, K. Nakagawa, M. Fukuoka   +20 more
semanticscholar   +1 more source

Lung cancer — major changes in the American Joint Committee on Cancer eighth edition cancer staging manual

Ca-A Cancer Journal for Clinicians, 2017
Ramon Rami-Porta, William D Travis, Valerie W Rusch   +2 more
exaly